Serotonin transporter and dopamine transporter imaging in the canine brain

Nuclear Medicine and Biology

Volumn 33, Issue 7, 2006, Pages 907-913

  Peremans, Kathelijne ^a   Goethals, Ingeborg ^b   De Vos, Filip ^a   Dobbeleir, A ^a   Ham, Hamphrey ^b   Van Bree, Henri ^a   Van Heeringen, Cees ^a   Audenaert, Kurt ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Dopamine transporter; Functional imaging; Serotonin transporter

Indexed keywords

2BETA CARBOXYMETHOXY 3BETA (4 IODOPHENYL)TROPANE I 123; CITALOPRAM; DOPAMINE TRANSPORTER; ESCITALOPRAM; N (3 FLUOROPROPYL) 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)NORTROPANE I 123; RADIOLIGAND; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DOG; DRUG EFFECT; FEASIBILITY STUDY; FEMALE; NEUROIMAGING; NONHUMAN; PROTEIN INTERACTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BRAIN; COCAINE; DOGS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEASIBILITY STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TROPANES;

EID: 33749432127     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2006.07.013     Document Type: Article

References (47)

1. 3H]paroxetine. Neuroscience 27 (1988) 473-496
2. 3H]imipramine. J Pharmacol Exp Ther 242 (1987) 364-371
3. 125I]PE2I. Neuroimage 9 (1999) 108-116
4. 125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain. Nucl Med Biol 24 (1997) 629-634
5. Kugaya A., Seneca N.M., Snyder P.J., Williams S.A., Malison R.T., Baldwin R.M., et al. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28 (2003) 413-420
6. Laruelle M., Baldwin R., Malison R., Zea-Ponce Y., Zoghbi S., Al-Tikriti M., et al. SPECT imaging of dopamine and serotonin transporters with (123I)beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 13 (1993) 295-309
7. 123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primates. Nucl Med Biol 27 (2000) 13-21
8. 123I]beta-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 94 (1993) 137-146
9. Kuikka J.T., Tiihonen J., Bergstrom K.A., Karhu J., Hartikainen P., Viinamaki H., et al. Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med 22 (1995) 346-350
10. 123I]beta-CIT binding to dopamine and serotonin transporters. Eur J Nucl Med 23 (1996) 431-436
11. 11C]DASB positron emission tomography study. Am J Psychiatry 161 (2004) 826-835
12. Peremans K., De Bondt P., Audenaert K., Van Laere K., Gielen I., Koole M., et al. Regional brain perfusion in 10 healthy dogs measured using technetium-99m ethyl cysteinate dimer SPECT: a normal database. Vet Radiol Ultrasound 42 (2001) 562-568
13. 123I-5-I-R91150 in the normal canine brain imaged with single photon emission computed tomography. Vet Radiol Ultrasound 44 (2002) 344-351
14. 123I]FPCIT SPECT. J Nucl Med 40 (1999) 753-761
15. Booij J., De Bruin K., de Win M.M., Lavini C., Den Heeten G.J., and Habraken J.B. Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible. Nucl Med Biol 30 (2003) 643-649
16. Knobelman D.A., Kung H.F., and Lucki I. Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors. J Pharmacol Exp Ther 292 (2000) 1111-1117
17. Smith T.D., Kuczenski R., George-Friedman K., Malley J.D., and Foote S.L. In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration. Synapse 38 (2000) 460-470
18. Benmansour S., Owens W.A., Cecchi M., Morilak D.A., and Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22 (2002) 6766-6772
19. de Win M.M., Habraken J.B., Reneman L., Van den Brink W., Den Heeten G.J., and Booij J. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology 30 (2005) 996-1005
20. 123I]ADAM: a SPECT validation study. Eur J Nucl Med Mol Imaging 32 (2005) 1329-1336
21. 123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49 (2001) 326-332
22. Pirker W., Asenbaum S., Kasper S., Walter H., Angelberger P., Koch G., et al. beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm Gen Sect 100 (1995) 247-256
23. Pogarell O., Poepperl G., Mulert C., Hamann C., Sadowsky N., Riedel M., et al. SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD). Eur Neuropsychopharmacol 15 (2005) 521-524
24. Suhara T., Sudo Y., Yoshida K., Okubo Y., Fukuda H., Obata T., et al. Lung as reservoir for antidepressants in pharmacokinetic drug interactions. Lancet 351 (1998) 332-335
25. Van Bockstaele E.J., Cestari D.M., and Pickel V.M. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons. Brain Res 647 (1994) 307-322
26. Parsons L.H., and JusticeJr J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606 (1993) 195-199
27. Clark R.N., Ashby Jr. C.R., Dewey S.L., Ramachandran P.V., and Strecker R.E. Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat. Synapse 23 (1996) 125-131
28. Ichikawa J., and Meltzer H.Y. Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur J Pharmacol 281 (1995) 255-261
29. Zhou F.M., Liang Y., Salas R., Zhang L., De Biasi M., and Dani J.A. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46 (2005) 65-74
30. Lesch K.P., and Mossner R. Inactivation of 5HT transport in mice: modeling altered 5HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes. Handb Exp Pharmacol (2006) 417-456
31. Tsukada H., Nishiyama S., Kakiuchi T., Ohba H., Sato K., and Harada N. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain. Synapse 42 (2001) 273-280
32. Elfving B., Bjornholm B., and Knudsen G.M. Interference of anaesthetics with radioligand binding in neuroreceptor studies. Eur J Nucl Med Mol Imaging 30 (2003) 912-915
33. Reneman L., Booij J., Lavalaye J., De Bruin K., De Wolff F.A., Koopmans R.P., et al. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain. Synapse 34 (1999) 77-80
34. 123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse 27 (1997) 183-190
35. 18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats. Synapse 47 (2003) 45-53
36. 18F]FE@CIT, a new potential tracer for the dopamine transporter. Synapse 55 (2005) 73-79
37. 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography. J Nucl Med 45 (2004) 673-681
38. Hipolide D.C., Moreira K.M., Barlow K.B., Wilson A.A., Nobrega J.N., and Tufik S. Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 297-303
39. Boothman L.J., Mitchell S.N., and Sharp T. Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis. Neuropharmacology 50 (2006) 726-732
40. Shen H.W., Hagino Y., Kobayashi H., Shinohara-Tanaka K., Ikeda K., Yamamoto H., et al. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29 (2004) 1790-1799
41. Minuzzi L., Olsen A.K., Bender D., Arnfred S., Grant R., Danielsen E.H., et al. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo. Synapse 59 (2006) 211-219
42. Rapoport J.L., Ryland D.H., and Kriete M. Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. Arch Gen Psychiatry 49 (1992) 517-521
43. Goldberger E., and Rapoport J.L. Canine acral lick dermatitis: response to the antiobsessional drug clomipramine. J Am Anim Hosp Assoc 27 (1991) 179-182
44. Denys D., Zohar J., and Westenberg H.G. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 65 Suppl 14 (2004) 11-17
45. Hesse S., Muller U., Lincke T., Barthel H., Villmann T., Angermeyer M.C., et al. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res 140 (2005) 63-72
46. Acton P.D., Kung M.P., Mu M., Plossl K., Hou C., Siciliano M., et al. Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM. Eur J Nucl Med 26 (1999) 854-861
47. 123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med biol 20 (1993) 597-606